Leave your feedback Share Copy URL https://gographicsoutput.com/video/bNkaSlWS3AB.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA reverses course, will review Moderna’s new mRNA flu vaccine [M9hUAmNZT4P] Health Updated on August 10, 2026 EDT — Published on August 10, 2026 EDT Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. edwhaKJibq2 Kz0HZR1MDaV BR7aasMGQpx SmjsGAoZiiU DRzaKz2BBjJ 9QyNcMASJcA
Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. edwhaKJibq2 Kz0HZR1MDaV BR7aasMGQpx SmjsGAoZiiU DRzaKz2BBjJ 9QyNcMASJcA